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Towards Better Understanding of Activin A Role in Keratinocyte Differentiation
The superfamily of transforming growth factor-β (TGF-β) includes
over 30 members that are divided into four groups: TGF-β, bone
morphogenetic proteins, growth/differentiation factors, and activins.
Activins have been implicated in cell growth inhibition and activin A
induces cell cycle arrest and apoptosis of cells that express its receptor.
It has been reported that activin A expression is upregulated in the
epidermis after cutaneous injury. Still, the precise effect of activin A
on keratinocytes has not been reported.
To investigate its effect on keratinocytes, Seishima et al (p. 432)
have added activin A to cultured human keratinocytes. They found
Substance p Abrogates and Prevents UV Induced Cutaneous Tolerance
Neuropeptides, including the calcitonin gene-related peptide (CGRP)
and substance-p, have been reported to play a role in cutaneous
hypersensitivity reactions. Previous publications report that topical
applications of substance-p increase the ear swelling in mice in response
to contact allergen, and that substance-p inhibitor decreases the
cutaneous response when injected at the site of contact allergen
application.
In this paper, Niizeki et al (p. 437) report that substance-p agonist
can abrogate and also prevent cutaneous tolerance induced by UV
irradiation; however, substance-p agonist failed to maintain the popula-
Blocking Epidermal Growth Factor Receptor Signaling Downregulates Bcl-xL in Keratinocytes
The survival of many cell types, including hematopoietic cells, neurons
and fibroblasts, depends on growth factors and cytokines. Through
interaction with their specific receptors these ligands activate a signaling
pathway leading to survival. In contrast, growth factor deprivation, or
interfering with receptor/ligand interaction, results in activation of
apoptotic signaling and leads to programmed cell death. Keratinocytes
are also dependent on survival/apoptotic signaling. In particular,
epidermal growth factor has been implicated as a survival factor for
keratinocytes. It is known to extend the life span of cultured ker-
atinocytes and to delay their terminal differentiation. Epidermal growth
factor binds a transmembrane tyrosine kinase receptor. Upon ligand
binding the intracellular portion of the receptor, which contains a
tyrosine kinase domain, becomes phosphorylated and this phosphoryla-
tion is required for signal transduction.
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that within 24 h, activin A decreased keratinocyte proliferation and
induced keratinocyte differentiation as determined by cornified envel-
ope formation and by increased synthesis of GTPase 1, loricrin, keratin
1, and involucrin.
Extracellular and intracellular signals that control the process of the
keratinocyte differentiation program have been extensively studied.
Still, the signaling mechanism that initiates the differentiation switch
has not been elucidated. The findings presented in this paper appear
to suggest that activin A may play a role during the initial modulation
of keratinocyte differentiation.
tion epidermal Langerhans cells when administered together with UV
irradiation, suggesting that substance-p effect on contact hypersensitivity
is mediated through its effect on dermal rather than epidermal antigen-
presenting cells.
This study confirms and expands pervious reports indicating that
neuropeptides of neuroneal origin have an effect on cutaneous hyper-
sensitivity reactions. Thus, cutaneous hypersensitivity reactions appear
to belong to an expanding group of dermatoses, including psoriasis,
urticaria, and atopic dermatitis, whose pathogenesis presents evidence
of a neurogenic component.
Jost et al (p. 443) now report that blocking the receptor for epidermal
growth factor with antagonistic antibodies, or inhibiting the activation
of its associated tyrosine kinase, results in downregulation of the anti-
apoptotic Bcl-xL protein rather than induction of apoptotic proteins
like Bad, Bak, and Bax.
This study contributes to our understanding of signaling mechanisms
that are mediated through activation of the epidermal growth factor
receptor. By upregulating the level of Bcl-xL, epidermal growth factor
facilitates the formation of Bcl-xL/Bax (or Bcl-xL/Bad, Bcl-xL/Bak)
heterodimers and prevents the formation of homodimers composed of
Bax/Bax, Bak/Bak, or Bad/Bad that are recognized to promote
apoptosis.
